Aratana Therapeutics, Inc. Net Profit Margin 2013-2019 | PETX
Aratana Therapeutics, Inc. net profit margin from 2013 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2019-03-31 |
$0.04B |
$-0.01B |
-33.33% |
2018-12-31 |
$0.04B |
$-0.02B |
-41.67% |
2018-09-30 |
$0.04B |
$-0.02B |
-53.66% |
2018-06-30 |
$0.03B |
$-0.04B |
-160.00% |
2018-03-31 |
$0.03B |
$-0.04B |
-176.00% |
2017-12-31 |
$0.03B |
$-0.05B |
-192.00% |
2017-09-30 |
$0.02B |
$-0.06B |
-366.67% |
2017-06-30 |
$0.01B |
$-0.06B |
-655.56% |
2017-03-31 |
$0.04B |
$-0.03B |
-66.67% |
2016-12-31 |
$0.04B |
$-0.03B |
-86.84% |
2016-09-30 |
$0.04B |
$-0.02B |
-60.53% |
2016-06-30 |
$0.04B |
$-0.06B |
-168.42% |
2016-03-31 |
$0.00B |
$-0.09B |
inf% |
2015-12-31 |
$0.00B |
$-0.08B |
inf% |
2015-09-30 |
$0.00B |
$-0.08B |
inf% |
2015-06-30 |
$0.00B |
$-0.04B |
inf% |
2015-03-31 |
$0.00B |
$-0.04B |
inf% |
2014-12-31 |
$0.00B |
$-0.04B |
inf% |